| First Author | Forsström S | Year | 2019 |
| Journal | Cell Metab | Volume | 30 |
| Issue | 6 | Pages | 1040-1054.e7 |
| PubMed ID | 31523008 | Mgi Jnum | J:282933 |
| Mgi Id | MGI:6384175 | Doi | 10.1016/j.cmet.2019.08.019 |
| Citation | Forsstrom S, et al. (2019) Fibroblast Growth Factor 21 Drives Dynamics of Local and Systemic Stress Responses in Mitochondrial Myopathy with mtDNA Deletions. Cell Metab 30(6):1040-1054.e7 |
| abstractText | Mitochondrial dysfunction elicits stress responses that safeguard cellular homeostasis against metabolic insults. Mitochondrial integrated stress response (ISR(mt)) is a major response to mitochondrial (mt)DNA expression stress (mtDNA maintenance, translation defects), but the knowledge of dynamics or interdependence of components is lacking. We report that in mitochondrial myopathy, ISR(mt) progresses in temporal stages and development from early to chronic and is regulated by autocrine and endocrine effects of FGF21, a metabolic hormone with pleiotropic effects. Initial disease signs induce transcriptional ISR(mt) (ATF5, mitochondrial one-carbon cycle, FGF21, and GDF15). The local progression to 2(nd) metabolic ISR(mt) stage (ATF3, ATF4, glucose uptake, serine biosynthesis, and transsulfuration) is FGF21 dependent. Mitochondrial unfolded protein response marks the 3(rd) ISR(mt) stage of failing tissue. Systemically, FGF21 drives weight loss and glucose preference, and modifies metabolism and respiratory chain deficiency in a specific hippocampal brain region. Our evidence indicates that FGF21 is a local and systemic messenger of mtDNA stress in mice and humans with mitochondrial disease. |
